| A large annotated medical image dataset for the development and evaluation of segmentation algorithms AL Simpson, M Antonelli, S Bakas, M Bilello, K Farahani, B Van Ginneken, ... arXiv preprint arXiv:1902.09063, 2019 | 944 | 2019 |
| The medical segmentation decathlon M Antonelli, A Reinke, S Bakas, K Farahani, A Kopp-Schneider, ... Nature communications 13 (1), 4128, 2022 | 728 | 2022 |
| Histone deacetylase 8 in neuroblastoma tumorigenesis I Oehme, HE Deubzer, D Wegener, D Pickert, JP Linke, B Hero, ... Clinical Cancer Research 15 (1), 91-99, 2009 | 457 | 2009 |
| Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience A Afshar-Oromieh, U Haberkorn, HP Schlemmer, M Fenchel, M Eder, ... European journal of nuclear medicine and molecular imaging 41, 887-897, 2014 | 375 | 2014 |
| “ToxRTool”, a new tool to assess the reliability of toxicological data K Schneider, M Schwarz, I Burkholder, A Kopp-Schneider, L Edler, ... Toxicology letters 189 (2), 138-144, 2009 | 334 | 2009 |
| Mutational activation of the β-catenin proto-oncogene is a common event in the development of Wilms’ tumors R Koesters, R Ridder, A Kopp-Schneider, D Betts, V Adams, F Niggli, ... Cancer research 59 (16), 3880-3882, 1999 | 303 | 1999 |
| Why rankings of biomedical image analysis competitions should be interpreted with care L Maier-Hein, M Eisenmann, A Reinke, S Onogur, M Stankovic, P Scholz, ... Nature communications 9 (1), 5217, 2018 | 293 | 2018 |
| Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease MO Wielpütz, M Puderbach, A Kopp-Schneider, M Stahl, E Fritzsching, ... American journal of respiratory and critical care medicine 189 (8), 956-965, 2014 | 290 | 2014 |
| Concordance analysis: part 16 of a series on evaluation of scientific publications R Kwiecien, A Kopp-Schneider, M Blettner Deutsches Ärzteblatt International 108 (30), 515, 2011 | 261 | 2011 |
| Modulation of benzo [a] pyrene diolepoxide–DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism M Rojas, I Cascorbi, K Alexandrov, E Kriek, G Auburtin, L Mayer, ... Carcinogenesis 21 (1), 35-41, 2000 | 256 | 2000 |
| HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth T Milde, I Oehme, A Korshunov, A Kopp-Schneider, M Remke, P Northcott, ... Clinical Cancer Research 16 (12), 3240-3252, 2010 | 239 | 2010 |
| Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA) CJ Portier, BK Armstrong, BC Baguley, X Baur, I Belyaev, R Bellé, ... J Epidemiol Community Health 70 (8), 741-745, 2016 | 228 | 2016 |
| Morphologic and functional scoring of cystic fibrosis lung disease using MRI M Eichinger, DE Optazaite, A Kopp-Schneider, C Hintze, J Biederer, ... European journal of radiology 81 (6), 1321-1329, 2012 | 221 | 2012 |
| CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma EM Noll, C Eisen, A Stenzinger, E Espinet, A Muckenhuber, C Klein, ... Nature medicine 22 (3), 278-287, 2016 | 213 | 2016 |
| Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization M Stassar, G Devitt, M Brosius, L Rinnab, J Prang, T Schradin, J Simon, ... British journal of cancer 85 (9), 1372-1382, 2001 | 212 | 2001 |
| High benzo [a] pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/MspI-GSTM1* 0/* 0 genotypes M Rojas, K Alexandrov, I Cascorbi, J Brockmöller, A Likhachev, ... Pharmacogenetics and Genomics 8 (2), 109-118, 1998 | 188 | 1998 |
| Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation I Rettig, E Koeneke, F Trippel, WC Mueller, J Burhenne, ... Cell death & disease 6 (2), e1657-e1657, 2015 | 183 | 2015 |
| Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab H Anwar, C Sachpekidis, J Winkler, A Kopp-Schneider, U Haberkorn, ... European journal of nuclear medicine and molecular imaging 45, 376-383, 2018 | 182 | 2018 |
| Assessment of morphological MRI for pulmonary changes in cystic fibrosis (CF) patients: comparison to thin-section CT and chest x-ray M Puderbach, M Eichinger, J Haeselbarth, S Ley, A Kopp-Schneider, ... Investigative radiology 42 (10), 715-724, 2007 | 179 | 2007 |
| Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer MT Freitag, JP Radtke, BA Hadaschik, A Kopp-Schneider, M Eder, ... European journal of nuclear medicine and molecular imaging 43, 70-83, 2016 | 174 | 2016 |
